» Articles » PMID: 32114424

Epigenetic Alterations in Cancer

Overview
Specialty Biology
Date 2020 Mar 2
PMID 32114424
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic and epigenetic modifications in DNA contribute to altered gene expression in aging and cancer. In human cancers, epigenetic changes such as DNA methylation, histone modifications, micro RNAs and nucleosome remodelling all control gene expression. The link between the genetics and epigenetics in cancer is further shown by existence of aberrant metabolism and biochemical pathways in cancer or mutation in genes that are epigenetic players. Reversal of these epigenetic changes has been clearly shown to have therapeutic value in various forms of lymphoma and preleukemia and similar results are appearing for the treatment of solid tumors. In this review, we discuss the functional effects of epigenetic changes inducible by hypoxia, the epigenetic alterations in cancer and how they contribute to tumor progression and their relevance to epigenetic therapy.

Citing Articles

Advances in epigenetic treatment of adult T-cell leukemia/lymphoma: a comprehensive review.

Letafati A, Mehdigholian Chaijani R, Edalat F, Eslami N, Askari H, Askari F Clin Epigenetics. 2025; 17(1):39.

PMID: 40025589 PMC: 11871821. DOI: 10.1186/s13148-025-01841-z.


Unveiling the effects of GSK126 on osteosarcoma cells implications for apoptosis, autophagy, and cellular migration.

Xiong X, Liu Y, Du Y, Lai X, Si C, Miao H Discov Oncol. 2025; 16(1):245.

PMID: 40014170 PMC: 11868014. DOI: 10.1007/s12672-025-02010-7.


Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence.

Tufail M, Jiang C, Li N Mil Med Res. 2025; 12(1):7.

PMID: 39934876 PMC: 11812268. DOI: 10.1186/s40779-025-00595-2.


Epigenetic Modifications as Novel Therapeutic Strategies of Cancer Chemoprevention by Phytochemicals.

Hsieh H, Kuo M, Chen I, Lin C, Hsu V, HuangFu W Pharm Res. 2025; 42(1):69-78.

PMID: 39775615 DOI: 10.1007/s11095-024-03810-2.


The Simultaneous Treatment of PC-3 Cells with the DNA-Demethylating Agent Decitabine and S-Adenosylmethionine Leads to Synergistic Anticancer Effects.

Schmidt T, Sticht C Genes (Basel). 2025; 15(12.

PMID: 39766901 PMC: 11675482. DOI: 10.3390/genes15121634.